|Articles|January 2, 2023
- Pharmaceutical Technology, January 2023
- Volume 47
- Issue 1
- Pages: 12
Biologics-Oriented Antibody Discovery Platform
Author(s)Pharmaceutical Technology Editors
Bio-Rad Laboratories’ Pioneer Antibody Discovery Platform is an antibody discovery service specifically designed to develop best-in-class biologic candidates.
Bio-Rad Laboratories Pioneer Antibody Discovery Platform is an antibody discovery service specifically designed to develop best-in-class biologic candidates. The platform, which includes more than 200 billion unique sequences, is capable of identifying high-affinity antibody candidates via Bio-Rad’s SpyDisplay selection technology; this technology is optimized for candidates suitable for drug development.
The platform is tailored to specific client requirements and uses proprietary TrailBlazer technology to provide prototypes of therapeutic antibodies in various formats for streamlined lead identification. Final immunoglobulin G antibodies are delivered functionally characterized with a complete data package and sequences. Customers retain exclusivity and ownership over antibody sequences produced from the platform.
Articles in this issue
over 3 years ago
Six Approaches Making the Most Significant Impact in the Futureover 3 years ago
Opening Up Opportunities in 2023over 3 years ago
Inhalation Vaccine Developmentover 3 years ago
Crossing the Same River Multiple Timesover 3 years ago
Predicting Pharma’s Futureover 3 years ago
Write it Down, Investigate, and Controlover 3 years ago
Cleaning Up in Bio/Pharmaover 3 years ago
Setting Goals for Sustainabilityover 3 years ago
The Growth and Emergence of Technology in the Outsourcing Spaceover 3 years ago
A Rocky Road Ahead for FDA and Industry
